DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre study
No Thumbnail Available
Authors
Basu, Supratik
Salhan, Beena
Hossain, Md Imran
Issue Date
2020-07-21
Journal
Type
Peer-Reviewed Publication
Keywords
Chemotherapy
Antineoplastic combined chemotherapy protocols
Cisplatin
Cyclophosphamide
Doxorubicin
Etoposide
Multiple myeloma
Prognosis
Treatment outcome
Mortality
Adverse effects
DPACE
DTPACE
VRDPACE
VTDPACE
Efficacy
Myeloma
Survival
Antineoplastic combined chemotherapy protocols
Cisplatin
Cyclophosphamide
Doxorubicin
Etoposide
Multiple myeloma
Prognosis
Treatment outcome
Mortality
Adverse effects
DPACE
DTPACE
VRDPACE
VTDPACE
Efficacy
Myeloma
Survival
Journal Title
European Journal of Haematology
Volume
105
Issue
2
Begin page
231
End page
233
Abstract
No abstract available.
Citation
Djebbari F, De Abrew K, Salhan B, Panitsas F, Hossain MI, Eyre TA, Willan J, Ramasamy K, Basu S, Jenner M, Kothari J. DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre study. Eur J Haematol. 2020 Aug;105(2):231-233. doi: 10.1111/ejh.13422. Epub 2020 Apr 21. PMID: 32268442.